Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

Presentation TCT 2014

The Impact of Wound Healing for Isolated Below the Knee Lesion Patients with Critical Limb Ischemia

Presenter: Masataka Kajiwara

September 16, 2014

Presentation TCT 2014

Against the Proposal!

Presenter: John R. Laird Jr

September 14, 2014

Presentation TCT 2014

For the Proposal!

Presenter: Mehdi H. Shishehbor

September 14, 2014

Presentation TCT 2014

Appropriate Use Criteria in the Periphery: Status Update

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Sahil A. Parikh

September 14, 2014

Presentation TCT 2014

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Mark H. Wholey

September 14, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation TCT 2014

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Jihad A. Mustapha

September 14, 2014

Presentation TCT 2014

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Lanfroi Graziani

September 14, 2014

Presentation TCT 2013

Optimal Antiplatelet Regimen for Critical Limb Ischemia due to Pure Isolated Infrapopliteal Lesions

Presenter: Junichi Tazaki, Keisuke Hirano, Osamu Iida, Daizo Kawasaki, Takeshi Kimura, Yusuke Miyashita, Yoshiaki Shintani, Yoshimitsu Soga, Nobuhiro Suematsu, Kenji Suzuki, Terutoshi Yamaoka, Yasutaka Yamauchi

January 31, 2013

Presentation TCT 2013

Long term effect of transcatheter intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia

Presenter: Jean-Claude Lubanda, Miroslav Chochola, Robert Pytlik, Ales Linhart

January 31, 2013

Presentation TCT 2013

Endovascular Intervention in Patients with Critical Limb Ischemia in Taiwan: Patient Outcomes in 333 Consecutive Limb Procedures with a 6-year Follow-up

Presenter: Hsuan Li Huang

January 31, 2013

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con!

Presenter: Alex Powell

October 23, 2012

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

Presenter: Thomas Zeller

October 23, 2012

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

The Impact of Wound Healing for Isolated Below the Knee Lesion Patients with Critical Limb Ischemia

Against the Proposal!

For the Proposal!

Appropriate Use Criteria in the Periphery: Status Update

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

The BEST and BASIL 2 Studies: Designs and Goals

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Optimal Antiplatelet Regimen for Critical Limb Ischemia due to Pure Isolated Infrapopliteal Lesions

Long term effect of transcatheter intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia

Endovascular Intervention in Patients with Critical Limb Ischemia in Taiwan: Patient Outcomes in 333 Consecutive Limb Procedures with a 6-year Follow-up

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con!

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content